A Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies (MI FREEE)

Mass General Brigham

Status and phase: Completed; Phase 4

Conditions: Coronary Artery Disease; Myocardial Infarction

Treatments: Other: Full drug coverage; Other: Usual coverage

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00566774

2007-P-000847/1

Details and patient eligibility

About

The objective of this randomized trial is to evaluate the effect of providing full prescription drug coverage (i.e. no co-pays, co-insurance or deductibles) for statins, beta-blockers, angiotensin converting enzyme inhibitors and angiotensin II receptor blockers to patients recently discharged from hospital after acute myocardial infarction.

Enrollment: 5,860 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• discharged alive from hospital after acute MI
• receive health services and prescription drug benefits through Aetna, Inc.

Exclusion criteria

• enrollment in a Health Savings Account (HSA) plan
• age ≥ 65 years of age at the time of hospital discharge
• plan sponsor has opted out of participating in the study
• receive only medical services or pharmacy coverage but not both through Aetna

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

5,860 participants in 2 patient groups

1

Experimental group

Treatment:

Other: Full drug coverage

2

Active Comparator group

Treatment:

Other: Usual coverage